Skip to main content
. 2009 Oct 30;6(11):2740–2751. doi: 10.3390/ijerph6112740

Table 2.

Relation between respiratory, and cardiac symptoms and PMexhaust exposure.

OR3 (95% CI4)
Per 1 μg·m−3 increase in exposure Per increase in exposure corresponding to the fifth to the 95thpercentile
Cough1 1.01 (0.28–3.64) 1.00 (0.75–1.34)
Chronic bronchitis1 0.78 (0.53–11.44) 0.95 (0.87–1.73)
Non–allergic rhinitis1 1.79 (0.45–7.17) 1.14 (0.83–1.56)
Wheezing1 1.99 (0.36–11.83) 1.17 (0.79–1.75)
Chest tightness1 2.34 (0.48–11.48) 1.21 (0.85–1.74)
Shortness of breath1 2.92 (0.46–18.65) 1.27 (0.84–1.94)
Cardiac diseases1 7.56 (1.40–40.68) 1.58 (1.08–2.31)
Cardiac diseases2 9.04 (1.62–50.42) 1.64 (1.12–2.43)
Hypertension1 4.65 (0.76–28.41) 1.42 (0.94–2.13)
1

Logistic regression model was adjusted for gender, age, body mass index (BMI), and smoking.

2

Logistic regression model was also adjusted for high blood pressure.

3

Odds ratio (OR)

4

Confidence interval (CI)